News

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
Hope S. Rugo, MD, FASCO, emphasized the importance of educating patients about proactive rash and diarrhea management while taking PI3K/AKT inhibitors.
The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, ...
Patients with psoriatic arthritis with a family history of psoriatic disease are diagnosed with psoriasis and psoriatic ...
Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...
Nicky, from Plymouth, said she has just been diagnosed with rheumatoid arthritis by doctors. She said she had many symptoms that she thought were normal.
Viral infections can sometimes cause itchy or painful rashes. Here’s a breakdown of the most common viral skin rashes, what they look like, and how to deal with them.
An unexpected sign of seasonal allergies: Watch out for these 2 types of rashes According to Rachna Shah, the allergist and immunologist who heads Loyola Medicine's pollen count in Chicago, skin ...
Patients applied the gel to the rash each day for 28 days, and treatment success was defined as a 1-grade or greater reduction in rash severity and/or improvement in at least five skin-specific ...
LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.
Topical treatment offers relief from painful skin rash caused by targeted cancer therapy by University of California, Los Angeles Editors' notes ...
A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor ...